Proposed drug supply chain rule is mere table ante for broad

So-called “rebates” drive up drug costs and make up 40 to 50 percent of list prices.

Related Keywords

, Senate Finance Committee , Us Department Of Health , Human Services , Partd Proposed Rule , Indirect Remuneration , Build Back Better , Pharmaceuticals Policy , Drug Pricing , Debate , Pharmacy Benefit Management , Pharmaceutical Industry , Healthcare Reform In The United States , Yformulary , Joe Biden ,